Component
Elesclomol
Elesclomol. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Oral elesclomol without extra copper supplementation rescued neonatal mortality in intestine-specific Ctr1 knockout mice.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/copper-research/35433682.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6ebf1fdc967be53f455383e4edc79468266a5685db3867ca04ce2e2ccc4f2617", "start_char": 0, "end_char": 1449, "text_sha256": "6ebf1fdc967be53f455383e4edc79468266a5685db3867ca04ce2e2ccc4f2617"}
- experimental_model
- Oral elesclomol in genetically copper-transport-defective animals
- exposure
- Oral drug exposure without additional copper supplementation
- limitations
- Animal rescue does not establish safety or efficacy in people. Intestinal CTR1 loss is a different block from mitochondrial SLC25A3 loss.
- nutrient_topic
- Copper research collection; topical membership is not evidence of a direct dietary effect. · Copper
- organism
- Mouse; separate Caenorhabditis elegans experiments
- plain_language
- The drug helped use existing dietary copper despite a missing intestinal entry route.
- primary_references
- [copper-p35433682] Oral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models. (2022). https://pubmed.ncbi.nlm.nih.gov/35433682/ DOI: 10.3389/fcell.2022.856300
- tissue_or_cell_type
- Intestine and whole-animal development
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Copper: transport, cuproenzymes, deficiency, excess and nutrient interactions (2026-09-17) · lines 598–609
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oral elesclomol in genetically copper-transport-defective animals · source_derived_draft · unverified_draft
### copper-elesclomol-intestinal-bypass Oral elesclomol without extra copper supplementation rescued neonatal mortality in intestine-specific Ctr1 knockout mice. Condition category: machinery_impairment nutrient_topic: Copper research collection; topical membership is not evidence of a direct dietary effect. plain_language: The drug helped use existing dietary copper despite a missing intestinal entry route. organism: Mouse; separate Caenorhabditis elegans experiments tissue_or_cell_type: Intestine and whole-animal development experimental_model: Oral elesclomol in genetically copper-transport-defective animals limitations: Animal rescue does not establish safety or efficacy in people. Intestinal CTR1 loss is a different block from mitochondrial SLC25A3 loss. exposure: Oral drug exposure without additional copper supplementation evidence_span: {"source_cache": "artifacts/copper-research/35433682.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6ebf1fdc967be53f455383e4edc79468266a5685db3867ca04ce2e2ccc4f2617", "start_char": 0, "end_char": 1449, "text_sha256": "6ebf1fdc967be53f455383e4edc79468266a5685db3867ca04ce2e2ccc4f2617"} [copper-p35433682] Oral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models. (2022). https://pubmed.ncbi.nlm.nih.gov/35433682/ DOI: 10.3389/fcell.2022.856300
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.